Skip to main navigation
Skip to search
Skip to main content
Sort by
Neuroscience
Multiple Sclerosis
100%
Natalizumab
23%
Relapsing Remitting Multiple Sclerosis
16%
Expanded Disability Status Scale
15%
Magnetic Resonance Imaging
13%
Ocrelizumab
12%
Magnetic Resonance Imaging
12%
Neurofilament
7%
Cognitive Disorder
6%
Secondary Progressive Multiple Sclerosis
6%
Magnetoencephalography
6%
Randomized Controlled Trial
5%
Neurodegeneration
5%
Keyphrases
Multiple Sclerosis
57%
Natalizumab
15%
Disease Activity
11%
Progressive multiple Sclerosis
11%
Relapsing-remitting multiple Sclerosis
11%
Expanded Disability Status Scale
10%
Multiple Sclerosis Treatment
9%
Ocrelizumab
8%
Healthy Controls
7%
Progressive MS
7%
Neurofilament Light (NF-L)
6%
Disease Duration
6%
Nine-hole Peg Test
5%
Disease-modifying Therapy
5%
Timed 25-Foot Walk
5%
Medicine and Dentistry
Multiple Sclerosis
52%
Magnetic Resonance Imaging
13%
Expanded Disability Status Scale
8%
Disease Modifying Therapy
5%